Jonathan Galli

Jonathan Galli practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Jonathan Galli's NPI, 1962821801, was assigned on April 8, 2014. Jonathan Galli graduated from University of Vermont College of Medicine in 2014. Jonathan Galli holds Utah license 9538389-1205.

Jonathan Galli's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Jonathan Galli's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Jonathan Galli is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health. Dmand AI also links Jonathan Galli to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jonathan Galli practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Jonathan Galli's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Jonathan Galli is licensed in Utah.

CMS data shows 220 Medicare services from Jonathan Galli across 3 procedure codes in 2024, for 92 Medicare patients. Medicare paid $10,695 for them. Every service was in an office.

CMS counts 92 Medicare patients who saw Jonathan Galli in 2024. The largest group is 65 to 74, with 41 patients. 52% of them have high blood pressure, and 49% have arthritis. 22% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jonathan Galli's median patient age at 62, with 66% women.

In 2024, Jonathan Galli wrote 884 Medicare Part D claims for 129 patients. 88% of them were for generic drugs. CMS names the drug for 653 of them, across 25 drugs with 11 or more claims each, at $849,693 in total drug cost. In 2023, CMS named 405 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Jonathan Galli for performance year 2024, reported as part of a group. Jonathan Galli accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Jonathan Galli as offering telehealth.

Dmand AI links 9 papers to Jonathan Galli, published from 2017 to 2023. 2020 was the busiest year, with 2. The most frequent topics are Autoantibodies, Central Nervous System Diseases and Glucocorticoids. Jonathan Galli has published most often in Neurol Neuroimmunol Neuroinflamm. Jonathan Galli's most frequent co-authors are Stacey L. Clardy, MD, PhD, John Edward Greenlee, MD and Karen Lisa Salzman, MD.

CMS Open Payments shows 2 general payments to Jonathan Galli from 1 drug or device company from 2018 to 2019. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $198.

Jonathan Galli graduated from University of Vermont College of Medicine in 2014.